(Total Views: 74)
Posted On: 11/04/2019 11:40:43 AM
Post# of 27102
$GE News Article - GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan(TM) (gadoterate meglumine) Injection for Intravenous Use https://marketwirenews.com/news-releases/ge-h...44680.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼